layout.fixed.naaccr.doc.naaccr22.alkRearrangement.html Maven / Gradle / Ivy

Go to download

Show more of this group Show more artifacts with this name
Show all versions of layout Show documentation

Framework that allows defining file formats (layouts) and use them to read and write data files.

There is a newer version: 6.1


    
        Item #
        Length
        Source of Standard
        Year Implemented
        Version Implemented
        Year Retired
        Version Retired
    
    
        3938
        1
        NAACCR
        2021
        21
        
        
    



NAACCR XML: Tumor.alkRearrangement




Description
Testing for ALK rearrangement is performed for patients with advanced non-small cell lung cancer (NSCLC) to identify tumors which are sensitive to small-molecule ALK kinase inhibitors.
Rationale
ALK rearrangement is recommended by treatment guidelines for patients with advanced lung cancer as a prognostic marker and factor in determining appropriate therapy. It is a new data item for cases diagnosed 01/01/2021+.
Codes

    
        
            0
            Normal

                ALK negative

                Negative for rearrangement, no rearrangement identified, no mutations (somatic) identified, not present, not detected


            
        
        
            1
            Abnormal Rearrangement identified/detected: EML4-ALK, KIF5B-ALK, TFG-ALK, and/or KLC1-ALK
        
        
            2
            Rearrangement identified/detected: Other ALK Rearrangement not listed in code 1
        
        
            4
            Rearrangement, NOS
        
        
            7
            Test ordered, results not in chart
        
        
            8
            Not applicable: Information not collected for this case

                If this information is required by your standard setter, use of code 8 may result in an edit error.
            
        
        
            9
            Not documented in medical record

                ALK Rearrangement not assessed or unknown if assessed
            
        
        
            Blank
            Diagnosis year is prior to 2021
        
        
            
        
    

Each Site-Specific Data Item (SSDI) applies only to selected primary
    sites, histologies, and years of diagnosis. Depending on applicability
    and standard-setter requirements, SSDIs may be left blank.

0	Normal ALK negative Negative for rearrangement, no rearrangement identified, no mutations (somatic) identified, not present, not detected
1	Abnormal Rearrangement identified/detected: EML4-ALK, KIF5B-ALK, TFG-ALK, and/or KLC1-ALK
2	Rearrangement identified/detected: Other ALK Rearrangement not listed in code 1
4	Rearrangement, NOS
7	Test ordered, results not in chart
8	Not applicable: Information not collected for this case If this information is required by your standard setter, use of code 8 may result in an edit error.
9	Not documented in medical record ALK Rearrangement not assessed or unknown if assessed
Blank	Diagnosis year is prior to 2021